Solvent-Free Fabrication of Robust Physical Hydrogels via Bulk Copolymerization for Underwater Acoustics
- PMID: 40538263
- DOI: 10.1002/adma.202508162
Solvent-Free Fabrication of Robust Physical Hydrogels via Bulk Copolymerization for Underwater Acoustics
Abstract
Conventional hydrogel preparation typically involves the use of solvents (mostly water), which increases the free volume between polymer chains and weakens their interactions, resulting in mechanically weak hydrogels with limited viscoelasticity. Here, a solvent-free synthesis strategy is presented to produce tough, swelling-resistant physical hydrogels with ultra-wide frequency viscoelasticity (loss factor tanδ > 0.3 at 10-10-105 Hz). This is achieved through the bulk copolymerization of highly miscible hydrophilic and hydrophobic monomers, forming water-free copolymers that develop into phase-separated hydrogels with dense chain entanglements upon equilibration in water. The resulting hydrogel exhibits significant mechanical enhancements over counterparts prepared through classical micellar copolymerization, with stiffness, strength, and fracture toughness increased by up to 81, 46, and 41 times, respectively. As a proof-of-concept demonstration, the tough hydrogel with excellent swelling resistance is applied as a sound-absorbing coating for underwater vehicles, minimizing acoustic interference during marine research through its strong viscoelasticity and near-perfect acoustic impedance matching with water. Unlike conventional solvent-assisted polymerization methods used for hydrogel preparation, bulk copolymerization offers advantages such as ultra-high monomer concentration, pure products, and straightforward process, providing new insights for developing simple yet tough hydrogels that are not only promising for underwater applications but also conducive to theoretical studies.
Keywords: bulk copolymerization; hydrogel; phase separation; swelling resistance; underwater sound absorption.
© 2025 Wiley‐VCH GmbH.
Similar articles
-
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19. Eur J Cancer. 2007. PMID: 17182241
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260. Health Technol Assess. 2001. PMID: 11701099
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
References
-
- G. Li, X. Chen, F. Zhou, Y. Liang, Y. Xiao, X. Cao, Z. Zhang, M. Zhang, B. Wu, S. Yin, Nature 2021, 591, 66.
-
- G. Li, T.‐W. Wong, B. Shih, C. Guo, L. Wang, J. Liu, T. Wang, X. Liu, J. Yan, B. Wu, Nat. Commun. 2023, 14, 7097.
-
- H. Fan, J. Wang, Z. Tao, J. Huang, P. Rao, T. Kurokawa, J. P. Gong, Nat. Commun. 2019, 10, 5127.
-
- J. Yu, R. Xie, M. Zhang, K. Shen, Y. Yang, X. Zhao, X. Zhang, Y. Zhang, Y. Cheng, Sci. Adv. 2023, 9, adg4031.
-
- M. Pi, S. Qin, S. Wen, Z. Wang, X. Wang, M. Li, H. Lu, Q. Meng, W. Cui, R. Ran, Adv. Funct. Mater. 2023, 33, 2210188.
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials